News
As a global leader in radiochemistry and molecular imaging and member of the Scientific Advisory Board for the AMTAR – housed at AIBN –Professor Jason Lewis, Deputy Director of the Sloan Kettering Institute in New York City, is well positioned to comment on the dramatic rise of radiopharmaceuticals over the last decade.
Talking to Seth Cheetham, a leading researcher in targeted therapeutics and biomanufacturing, and the new director of the National Biologics Facility
Join The Network
Stay on top of our industry news and developments, events and opportunities, by joining The Network
Meet our researchers
Read nowFollow us
Features
Researchers from The University of Queensland are using synthetic biology to help the world’s biggest businesses transition to net zero.
Work on a new range of hyper accurate cancer drugs has begun with the launch of an Australian-first research and manufacturing hub.
- 31 March 2026
- 27 February 2026
- 1 October 2025
- 22 September 2025
- 3 September 2025
Partner with us
Contact us and learn how our scientific expertise and cutting edge facilities could help you reach your goals.
